CD55 antibody (AA 71-300)
Quick Overview for CD55 antibody (AA 71-300) (ABIN1886629)
Target
See all CD55 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 71-300
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 71 and 300 of human CD55
-
-
-
-
Application Notes
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Alternative Name
- CD55
-
Background
-
This gene encodes a protein involved in the regulation of the complement cascade.The encoded glycoprotein is also known as the decay-accelerating factor (DAF), binding of DAF to complement proteins accelerates their decay, disrupting the cascade and preventing damage to host cells.Antigens present on the DAF glycoprotein constitute the Cromer blood group system (CROM).Two alternatively spliced transcripts encoding different proteins have been identified.The predominant transcript encodes a membrane-bound protein expressed on cells exposed to plasma component proteins but an alternatively spliced transcript produces a soluble protein present at much lower levels.Additional, alternatively spliced transcript variants have been described, but their biological validity has not been determined.[provided by RefSeq]
-
Molecular Weight
- 41 kDa
-
Gene ID
- 1604
-
NCBI Accession
- NM_000574, NP_000565
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity
Target
-